Do All Your Detailing Efforts Pay Off? Dynamic Panel Data Methods Revisited by Chung, Doug Jin et al.
Do All Your Detailing Efforts Pay Off?
Dynamic Panel Data Methods Revisited
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Chung, Doug J., Byungyeon Kim, and Byoung Park. "Do All Your
Detailing Efforts Pay Off? Dynamic Panel Data Methods Revisited."
Harvard Business School Working Paper, No. 17-108, June 2017.
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33110110
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Open Access Policy Articles, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#OAP
 Do All Your Detailing Efforts Pay Off? 
Dynamic Panel Data Methods Revisited   
Doug J. Chung 
Byungyeon Kim 
Byoung Park    
Working Paper 17-108 
  
Working Paper 17-108 
 
 
Copyright © 2017 by Doug J. Chung, Byungyeon Kim, and Byoung Park 
Working papers are in draft form. This working paper is distributed for purposes of comment and discussion only. It may 
not be reproduced without permission of the copyright holder. Copies of working papers are available from the author. 
 
 
 
Do All Your Detailing Efforts Pay Off? 
Dynamic Panel Data Methods Revisited  
  
Doug J. Chung 
Harvard Business School 
Byungyeon Kim 
Harvard Business School 
Byoung Park 
University of Albany  
 
 
 Do All Your Detailing Efforts Pay Off?  
Dynamic Panel Data Methods Revisited  
 
Doug J. Chung, Harvard University 
Byungyeon Kim, Harvard University 
Byoung Park, University at Albany 
 
June 2017 
 
Abstract 
We estimate a sales response model to evaluate the short- and long-term value of pharmaceutical 
sales representatives’ detailing visits to physicians of different types. By understanding the 
dynamic effect of sales calls across heterogeneous doctors, we provide guidance on the design of 
optimal call patterns for route sales. Our analyses reveal that the long-term persistence effect of 
detailing is more pronounced for specialist physicians; the contemporaneous marginal effect is 
higher for generalists. Free samples have little effect on any type of physician. We also introduce a 
key methodological innovation to the marketing and economics literatures. We show that moment 
conditions—typically used in traditional dynamic panel data methods—are vulnerable to serial 
correlation in the error structure. However, traditional tests to detect serial correlation have weak 
power and can be misleading, resulting in misuse of moment conditions and incorrect inference. 
We present an appropriate set of moment conditions to properly address serially correlated errors 
in analyzing dynamic panel data. 
 
Key words: dynamic panel data, serial correlation, instrumental variables, sales call, detailing, 
pharmaceutical industry.   
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1.  Introduction 
The pharmaceutical industry plays a significant role in the world economy. According to 
QuintilesIMS (formerly IMS Health), the global market for prescription drugs is expected to grow 
from roughly $1.1 trillion in 2016 to $1.5 trillion by 2021. Despite the enormous size of this market, 
however, marketing to customers (that is, to physicians) largely consists of (and is typically 
restricted to) personal selling in the form of detailing and free samples provided during office 
visits. 1  Even in the United States, a nation that allows direct-to-consumer mass-media 
pharmaceutical advertising, personal selling remains the dominant marketing tool; some 90,000 
sales representatives (1 for every 6.3 doctors) market pharmaceutical products to 567,000 U.S. 
physicians  (Wall and Brown, 2007). 
Studies of the effectiveness of personal selling at generating physician prescriptions have 
produced strikingly mixed findings in the literature: reported sales elasticity measures range from -
14.8% (Parsons and Vanden Abeele, 1981) to 41% (Gönül et al., 2001). This extreme 
inconsistently appears to be attributable both to limited data on physicians’ prescribing behavior 
and to bias arising from naive treatment of data, specifically panel data. Thus we seek to gain 
insights on deriving an unbiased measure of the short- and long-term value of a firm’s detailing 
efforts. To do so, we use detailed data on both individual physicians’ prescriptions and on the 
marketing efforts of a major multinational pharmaceutical firm. We also employ innovative 
dynamic panel data methods to control for unobserved physician heterogeneity while accounting 
for endogeneity concerns. 
                                                            
1 As of 2016, direct-to-consumer advertising is allowed only in Brazil, New Zealand, and the United States, with varying 
restrictions on content. 
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To obtain a precise and unbiased value of detailing efforts turns out to be quite complicated. 
Physicians’ prescribing behavior appears to be highly habitual, and this underlying heterogeneity 
is unobserved by researchers. Physicians are known to exhibit high levels of inertia (Janakiraman 
et al., 2008); an individual physician’s past level of prescriptions is likely to persist, affecting 
current sales. To accommodate this dynamic process, studies in marketing have frequently 
adopted the advertising-as-investment framework of Nerlove and Arrow (1962), which 
conceptualizes a sales response model as a function of a stock of goodwill that grows in response to 
current marketing activities but decays over time. According to typical assumptions used in the 
literature, this stock of goodwill—represented by the geometric sum of marketing efforts—can be 
replaced by the lagged dependent variable, leading to a general dynamic panel data model 
specification (Balestra and Nerlove, 1966). 
Identifying the causal effect of a sales call becomes challenging when this lagged dependent 
variable coincides with unobserved heterogeneity. Because pharmaceutical companies are likely to 
allocate more resources (e.g., shorter call cycles and more free samples) to physicians with higher 
sales-volume or growth potential, it is necessary to control for possible correlation between sales 
effort and potential. Moreover, an endogeneity problem arises because, by construction, the lagged 
dependent variable is correlated with lagged error terms through unobserved heterogeneity. Past 
studies have responded to this challenge by disregarding the issue (Parsons and Vanden Abeele, 
1981; Manchanda et al., 2004), fixing the rate of decay (Gönül et al., 2001), or excluding dynamics 
(Manchanda and Chintagunta, 2004). 
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Dynamic panel data methods proposed by Arellano and Bond (1991), Arellano and Bover 
(1995), and Blundell and Bond (1998) provide a practical approach to tackling the endogeneity 
problem while simultaneously accounting for unobserved heterogeneity. The key advantage of 
these methods is that they allow us to control for potential bias without relying on strictly 
exogenous instrumental variables, which in many empirical settings are impossible to obtain. 
Because of their practicality, dynamic panel data methods have been used in numerous contexts, 
including advertising (Clark et al., 2009; Xiong and Bharadwaj, 2013), customer-relationship 
management (Tuli et al., 2010), social media and online reviews (Borah and Tellis, 2016; Ludwig 
et al., 2013), and sales-call effectiveness (e.g., Mizik and Jacobson, 2004). 
Nevertheless, under the Nerlove and Arrow (1962) advertising-as-investment framework, the 
use of dynamic panel data methods is afflicted by a troubling issue: namely, hinging on the 
geometric sum assumption, the linkage between the framework and the dynamic panel data 
structure, by construction, encompasses serially correlated errors. Yet the validity of traditional 
dynamic panel data methods relies on the assumption that the error structure does not exhibit 
serial correlation. If serial correlation is present, the moment conditions derived under these 
methods become invalid, resulting in unreliable inference.  
To test for the validity of the moment conditions, and thus the model specification, past 
studies have relied on the Arellano-Bond test for serial correlation (Arellano and Bond, 1991). 
When the AR(2) test statistic is not rejected, presumably indicating an absence of serial 
correlation in the error structure, researchers have proceeded with the estimation without further 
concern. We show that the Arellano-Bond specification test is prone to weak power in detecting 
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serial correlation: the test statistic may fail to detect serial correlation, justifying the use of invalid 
moment conditions that result in biased estimates. We discuss technical shortcomings of the 
Arellano-Bond specification test and specify conditions where the test may fail to reject the 
misspecified model. 
To obtain unbiased estimates for identifying the causal effect of detailing, we present an 
adequate set of moment conditions in analyzing dynamic panel data. We provide proof that test 
statistics used to detect serial correlation are biased when using invalid moment conditions, and 
that traditional dynamic panel data methods fail once the assumption on serial correlation is eased. 
We formulate valid moment conditions that are robust to serial correlation. To validate our claims, 
we conduct Monte Carlo simulations to show that traditional methods yield biased estimates 
under serially correlated errors. The simulation results also reveal the weak power of the Arellano-
Bond specification test using traditional moment conditions, when serial correlation is present. 
We apply our method to a comprehensive panel dataset from a multinational pharmaceutical 
company, which includes detailed data on individual doctors’ prescribing histories and on sales 
representatives’ personal selling efforts on behalf of the firm. We postulate that when serial 
correlation is present, traditional methods yield biased and counterintuitive estimates implying 
negative effectiveness of detailing. By correcting for the misuse of invalid moment conditions, we 
find, on aggregate, that detailing efforts have a significant impact on physicians’ prescription rates. 
Subsequently, we allow for heterogeneity in the slope parameters to account for differences in 
the effectiveness of detailing from one medical practice area to another. We find, in general, that 
specialist physicians (cardiologists, diabetologists, and endocrinologists) exhibit greater persistence 
5 
 
in prescribing patterns and thus a long-term effect; by contrast, generalists (consulting physicians, 
general practitioners, and general surgeons) are more responsive to short-term detailing efforts but 
exhibit less persistence. In terms of magnitude, the effectiveness of sales calls tends to be highly 
heterogeneous across medical practice areas, ranging from insignificant to a 25% increase in 
prescriptions. Our simple but methodologically robust approach can help firms design optimal call 
patterns and sales targets to increase the overall efficiency of the sales force. 
The remainder of the paper is organized as follows. Section 2 presents our methodology, which 
builds on traditional dynamic panel data methods and eases their assumptions on serial 
correlation. Section 3 addresses the conditions in which the test for serial correlation is prone to 
weak power; Section 4 conducts simulation tests to verify our claims. Section 5 presents our 
empirical application and results for inference, and Section 6 concludes. 
2.  Dynamic Panel Data Revisited 
Dynamic panel data models have played a pivotal role in analyzing marketing and economic 
phenomena of a dynamic nature. A typical linear dynamic panel data model follows the form: 
    , 1it i t it i ity y x z ul b g- ¢ ¢= + + +     (1) 
it i itu ea= +         (2) 
where i=1,2,…,N, indexes cross-sectional units and t=2,3,...,T, indexes time. The scalar yit is the 
dependent variable of interest, observed at the individual level, and the recursive nature of the 
lagged dependent variable yi,t-1  on the right-hand side is the source of dynamics in the model. The 
vector xit (kx×1 dimension) represents time-varying independent variables, and the vector zi (kz×1 
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dimension) represents time-invariant independent variables. The parameters l , b , and g  denote 
the carryover effect and marginal effects with regard to xit and zi respectively. The data consist of 
(yi1, yi2,..., yiT), (xi1, xi2,..., xiT), and zi for i=1, 2,..., N, implying a dimension of N×T observations. 
The focus in dynamic panel data analysis is mainly on the case where N is large and T is small—
typical data available in dynamic panel data settings.  
The unobservable term uit consists of two components, individual unobserved heterogeneity ai 
and an idiosyncratic error eit.  The structure of the unobservable term in Equation (2) raises an 
endogeneity problem as the time-invariant unobserved heterogeneity component ai is correlated 
with the lagged dependent variable yi,t-1. This issue can be dealt with in a relatively 
straightforward manner by taking the first difference of Equation (1) to subtract out ai. 
However, the endogeneity problem with regard to the idiosyncratic error term eit—that is, the 
lagged dependent variable yi,t-1 being correlated with the lagged unobservables eis for s<t—remains 
a concern. The dynamic panel data methods proposed by Anderson and Hsiao (1981, 1982), and 
further developed by Arellano and Bond (1991), Arellano and Bover (1995), and Blundell and 
Bond (1998), utilize lagged levels and lagged differences as instruments to deal with this 
endogeneity issue, but their instruments are fully valid only under the assumption that the 
idiosyncratic errors eit are uncorrelated over time. 
We show that traditional tests to detect serial correlation have weak power and can be 
misleading, resulting in a misuse of moment conditions that leads to incorrect inference. The 
revised approach that we propose utilizes a set of moment conditions that is immune to serial 
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correlation in the error structure, highly likely in naturally occurring data. Before presenting our 
methodology, we will outline the key components of the traditional dynamic panel data models 
that serve as building blocks. We will then present our method and check its robustness using 
Monte Carlo simulations.  
2.1.  Traditional Dynamic Panel Data Methods 
For expository purposes, we assume for now that vectors xit and zi are absent. We denote eit as 
an idiosyncratic error term, which is assumed to be serially uncorrelated. The following model 
structure has been widely discussed in the economics literature (Anderson and Hsiao, 1981, 1982; 
Arellano and Bond, 1991; Arellano and Bover, 1995; and Blundell and Bond, 1998): 
     , 1it i t ity y ul -= +       (3) 
it i itu a e= +        (4) 
where all variables are independently and identically distributed across i, and 1l < . The 
idiosyncratic error component eit in Equation (4) satisfies the following standard assumptions: 
E[ ] 0ite =  for all t (mean zero), E[ ] 0it ise e =  for all t s¹  (no serial correlation), E[ ] 0i ita e =  for 
all t (orthogonal to individual effects), and 1E[ ] 0i ity e =  for all t (orthogonal to initial condition). 
Under these assumptions, the following linear moment conditions can be derived: 
     2E[ ] 0ti ity u- D =       (5) 
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where 1 2( , , , )'ti i i ity y y y=   and , 1it it i tu u u -D = - .2 As proposed by Arellano and Bond (1991), the 
estimator utilizing the moment conditions in Equation (5) is commonly referred to as the 
Difference GMM (DGMM) estimator. The key concept of DGMM is to use the lagged variables in 
levels as instruments for the first differenced equation. A potential downside of the DGMM 
estimator is that lagged levels become weak instruments for the first difference as 1l » , a case 
when the lagged levels take a random walk and convey limited information (Staiger and Stock, 
1997; Stock et al., 2002). 
As a remedy, the mean stationarity assumption, 2E[ ] 0i iya D = , can be imposed to yield the 
initial condition of the data. Provided the assumption holds, the first period observation of y is 
written as 1 1
i
i iy al h-= + , where ih  has zero mean and is uncorrelated with ia . This implies that 
the deviation of the first observation from the stationarity level, 1
ia
l- , is uncorrelated with the 
individual effects. Combining the initial condition with the orthogonality to individual effects 
assumption ( E[ ] 0i ita e =  for all t), we can derive 3 2E[ ] 0i iu yD = . Hence, by iteration, the 
following linear moment conditions become further available: 
     , 1E[ ] 0it i tu y -D = .     (6) 
As proposed by Arellano and Bover (1995) and Blundell and Bond (1998), the System GMM 
(SGMM) estimator creates a stacked dataset and utilizes both lagged levels to instrument for 
differences (Equation (5)) and lagged differences to instrument for levels (Equation (6)). Thus 
                                                            
2 For purposes of brevity, superscript t is used throughout the paper to denote a vector of all observations prior to time 
t. For example, yit=(yi1, yi2,..., yit)', and for the entire time horizon yiT=(yi1, yi2,..., yiT)'. Also, following the standard 
notation in the literature, the capital Greek letter delta D represents a first-difference operator. For example, Duit = 
uit-ui,t-1 and Dyit = yit-yi,t-1. 
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the SGMM estimator extracts more information from the data, and benefits from an increased 
number of moment conditions. Though the mean stationarity assumption is not necessary for 
identification, it contributes to the efficiency gain of the estimators by providing more linear 
moment conditions. In terms of the available number of moment conditions, there are ( 1)( 2)2
T T- -  
conditions in Equation (5) for DGMM estimators, and additional (T-2) conditions in Equation 
(6) for SGMM estimators. 
2.2.  A Motivating Example: The Advertising-as-Investment Model 
Though traditional methods have played a significant role in the dynamic panel data literature, 
the key underlying assumption that ite  is serially uncorrelated remains questionable. As a 
motivating example, let us consider the advertising-as-investment model of Nerlove and Arrow 
(1962), which has been widely applied in the marketing literature: 
( ),
0
j
it i i t j i it
j
y x za l b g n
¥
-
=
¢= + + +å   
where yit denotes sales and xit denotes the advertisement expenditure of firm i at time t. The 
model captures the long-term effects of advertisement using an infinite lag distribution model. 
Because part of the infinite geometric sum can be replaced by , 1i tyl - , this model simplifies to: 
    , 1it i t it i ity y x z ul b g- ¢= + + +   
    , 1it i it i tu a n ln -= + -   
where ( )1g l g= -   and ( )1i ia l a= -  . Hence, the unobserved term uit is shown to exhibit serial 
correlation caused by the error component , 1i tn - . 
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2.3.  Correcting for Serial Correlation in the Error Component 
Next we will consider our serial correlation corrected (hereafter, SCC) approach, which 
accounts for serial correlation in the error structure. The idiosyncratic error term in Equation (2) 
is now modified to exhibit serial correlation, , 1it it i te n ln -= - : 
     , 1it i t ity y ul -= +       (7) 
, 1it i it i tu a n ln -= + -      (8) 
where, again, all variables are i.i.d. across i, and 1l < . Now the error term uit is decomposed into 
time-invariant individual effects ia  and the time-varying error component itn .3 Through the term 
itn , the model exhibits serial correlation that introduces additional dynamics into the model. The 
assumptions from Equation (4) are modified to accommodate the new error structure regarding 
itn  in Equation (8) as follows: E[ ] 0itn =  for all t (mean zero), E[ ] 0it isn n =  for all t s¹  (no 
serial correlation outside the error structure), E[ ] 0i ita n =  for all t (orthogonal to individual 
effects), and 1E[ ] 0i ity n =  for all  2t ³  (orthogonal to initial condition). 
Now let us consider the valid moment conditions under the serially correlated errors. For 
traditional DGMM estimators, the intuition behind the moment conditions 2E[ ] 0ti ity u
- D =  in 
Equation (5) is that , 1it it i tu e e -D = -  is uncorrelated with ise  for any 2s t< - , and thus is 
orthogonal to isy  for 2s t< - . However, due to serial correlation, , 1it i tn ln -- , in Equation (8), 
we have , 1 , 2(1 )it it i t i tu n l n ln- -D = - + + , which contains an error from t-2. Thus in this case
                                                            
3 We also investigated the specification , 1it it i t ite n ln e-= - + , which disentangles the serially uncorrelated shocks. 
The resulting proof and moment conditions are largely analogous; we omit them for brevity.  
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, 2E[ ] 0i t ity u- D ¹  as both terms share the common , 2i tn - . However, the moment conditions for t-3 
and earlier remain valid. Hence, the moment conditions in Equation (5) are modified by the 
following ( 2)( 3)2
T T- -  set of conditions for the DGMM estimator under the serially correlated error 
structure assumption: 
     3E[ ] 0ti ity u
- D =       (9) 
for t=4,5,...,T. 
The loss of moment conditions reduces the efficiency of the estimator. The problem may be 
particularly significant under two circumstances often encountered in practice. The first occurs 
when the length of the observed time periods T is short: the shorter the observed length, the 
larger the proportion of invalid moment conditions becomes. The second case takes place when the 
weak-instrument problem is present. Blundell and Bond (1998) show that the instruments become 
weak when l  is close to 1. That is, ,Cov( , )i t r ity y- D  for 2r ³  leans to zero as l  tends to unity. 
Since the covariance decreases as r increases, yi,t-2 is a stronger (or, more precisely, less weak) 
instrument for ityD  than yi,t-r for 3r ³ . Thus, the instruments that become invalid under the new 
assumptions happen to be the strongest among the weak, exacerbating the weak-instrument 
problem. 
Analogous to the traditional approach, the mean stationarity assumption can be induced to 
alleviate the above issue. The initial condition for the SCC approach can be derived analogously 
given the mean stationarity assumption 2E[ ] 0i iya D = . However, the expression for yi1 is modified 
to incorporate 1in  by 1 11 ii i iy al n h-= + + , where 1E[ ] E[ ] E[ ] 0i i i i ih a h n h= = = . Unlike the 
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traditional approach in Equation (6), however, in the SCC approach 3 2E[ ] 0i iu yD ¹  due to the 
presence of 2in  in both ui3 and 2iyD . Instead, we have 4 2E[ ] 0i iu yD = . The lagged differences 
should also be at least two periods to avoid the common error component. Hence, the T-2 number 
of moment conditions from the traditional approach in Equation (6) is replaced in the SCC 
approach by the following T-3 conditions: 
     , 2E 0it i tu y -é ùD =ê úë û      (10) 
for t=4,5,...,T, to yield a SGMM estimator under serially correlated errors.  
2.4.  General Framework 
We now return to the general form of the dynamic panel data model in Equation (1), and 
discuss the moment conditions pertinent to the explanatory variables xit and zi. The error term in 
Equation (2) is altered on the basis of the SCC method to , 1it it i te n ln -= - : 
    , 1it i t it i ity y x z ul b g- ¢ ¢= + + +  
, 1it i it i tu a n ln -= + -  
for i=1,2,...,N and t=2,3,...,T. To define moment conditions with regard to regressors, one needs 
to comprehend their potential correlation with the individual effects. Following Hausman and 
Taylor (1981), we partition the vector of the independent variables as 1 2( , )it it itx x x=  and 
1 2( , )it i iz z z= . x1it and z1i are vectors orthogonal to the individual effects, whereas x2it and z2i are 
not—that is, the latter are correlated with the individual effects. In addition to the assumptions 
specified in Section 2.3, the following standard assumptions with regard to the regressors hold: 
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E[ ] 0it isx n =  for all t<s (xit is predetermined with respect to itn ), E[ ] 0i itz n =  for all t (zi is 
orthogonal to idiosyncratic errors), 1 1E[ ] E[ ] 0it i i ix za a= =  for all t (x1it and z1i are orthogonal to 
individual effects), and 2E[ ]it i xx aa = S  for all t (correlation between x2it and individual effects is 
constant over time). 
Predetermined variables, as the term implies, are variables whose values are determined by 
observations prior to the current period. Thus current-period errors are uncorrelated with current 
and lagged values, but not necessarily with future values, of predetermined variables. Utilizing 
predetermined variables in panel data models has been discussed in Hausman and Taylor (1981), 
Amemiya and MaCurdy (1986), and Breusch et al. (1989). Under the above assumptions, and 
accounting for serial correlation in the error structure, the following moment conditions are 
available for estimation: 
    1E[ ] 0  for 1it isx u t s= £ -  
    2E[ ] 0  for 2it isx u t sD = £ -  
    2 , 2E[ ] 0  for 4,5,...,i t itx u t T-D = =     (11) 
    1E[ ] 0  for 1,2,...,i itz u t T= =  
    2E[ ] 0  for 1,2,...,i itz u t TD = = . 
3.  Failure of Tests for Serial Correlation 
It is crucial to check for the presence of serially correlated errors, which determines the 
construction of the moment conditions used for estimation. The Arellano and Bond (1991) 
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specification test—specifically, the AR(2) test—has been widely employed in empirical 
applications to check for serial correlation in idiosyncratic errors. 
However, the AR(2) test may generate unreliable results when test statistics are constructed 
using biased estimators obtained from invalid moment conditions (Bowsher (2002), for example, 
finds that AR tests have extremely low power in finite samples). For expository purposes, let us 
suppose that there exists serial correlation in the errors. The previous section showed that 
estimators from traditional methods can be biased because they are obtained using invalid 
moment conditions. Nevertheless, in the test procedure these biased estimators are recursively 
utilized to calculate the error components in the model—which are also likely to become biased. 
As the basis of the test statistic becomes biased, the AR(2) test exhibits weak power and may fail 
to reject the null hypothesis of no serial correlation.  
We now elaborate on this argument. Let us suppose that the true model is represented by 
Equations (7) and (8), where the error structure is serially correlated. However, without 
knowing whether serial correlation is present, suppose we estimate l  in Equation (3) using the 
traditional moment conditions given by Equation (5). Here we are particularly interested in 
testing the null hypothesis of no serial correlation , 1E[ ] 0it i te e - =  against its negation. Because 
there exists first-order serial correlation in levels, we have 2, 1 , 1E[ ] E( ) 0it i t i te e l n- -=- ¹  for all t. 
Thus, the moment conditions in Equation (5) become invalid because 
2
, 2 , 2E[ ] E( ) 0i t it i ty u l n- -D = ¹ . In this case the GMM estimator lˆ  is expected to be downward-
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biased because the sign of the correlation between , 1i ty -D  and ituD  is negative (assuming 0l > ); 
thus the misspecification bias would also be negative. For brevity, let ˆ( )B E l l= -  be the bias. 
To check for first-order serial correlation in levels, the Arellano-Bond AR(2) test looks at the 
second-order correlation in differences. In other words, , 2E[ ] 0it i tu u -D D =  only when the null 
hypothesis is true. Let  , 1ˆit it i tu y yl -D = D - D  be the sample estimate of ituD . Due to the bias in 
lˆ , the estimate  , 1it it i tu u B y -D » D - D  is also contaminated. By replacing this expectation with 
the sample counterparts, we have: 
 2
, 2 , 2 , 1 , 2 , 3 , 1 , 3E[ ] E[ ] E[ ] E[ ] E[ ]it i t it i t i t i t i t it i t i tu u u u B y u B y u B y y- - - - - - -D D » D D - D D - D D + D D . 
For illustrative purposes, let us further assume homoskedasticity in differences (i.e., 2 2( )itE nn s=  
for all t). Substituting the components in Equations (7) and (8) causes the above terms to 
become: 
    2, 2E[ ] 0it i tu u nls-D D = >   
    2, 1 , 2E[ ]i t i ty u ns- -D D =-  
    , 3 , 1 , 3E[ ] E[ ] 0i t it i t i ty u y y- - -D D = D D =  
Note that, under absence of bias (B=0), , 2E[ ]it i tu u -D D  would converge to 2nls , and the degree 
of serial correlation captured by l  and 2ns  would jointly determine the test statistic. However, 
when lˆ  becomes biased, , 2E[ ]it i tu u -D D  would converge to 2( )B nl s+ , and, because B is likely 
negative, , 2E[ ]it i tu u -D D  would become downward-biased. Thus, depending on the degree of bias in 
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lˆ , the test statistic based on , 2E[ ]it i tu u -D D  may falsely infer that , 2E[ ] 0it i tu u -D D =  and fail to 
reject the null hypothesis, conferring validity on incorrect inference.  
The essence of this problem is a trade-off between efficiency and robustness. Although the test 
statistic utilizing all moment conditions in Equation (5) is expected to be more efficient, this 
efficiency gain does not materialize due to some invalid moment conditions. Rather, in this case, 
the cost of the misspecification bias dominates the benefit of using more moment conditions, 
particularly in finite samples. In Section 4, we verify these assertions using simulation studies, and 
demonstrate the poor performance of the test statistic under traditional methods when serial 
correlation is present. 
4.  Simulation Study 
To compare and evaluate the performance of different estimators and of the Arellano-Bond 
specification test, we run Monte Carlo experiments using simulated data. We set the data-
generating process to follow a simple form of the model with one predetermined variable (kx=1): 
     , 1it i t it ity y x ul b-= + +  
where uit does not exhibit serial correlation ( it i itu a e= + ) in Case 1 and does so 
( , 1it i it i tu a n ln -= + - ) in Case 2. Utilizing the typical structure of dynamic panel data in a real-
world setting, where N is large and T is small, we simulate data for N=1,000 and T=10. For each 
setting, we run 200 Monte Carlo iterations and report the mean values of the estimates. In 
interpreting the results, the terms traditional approach and SCC approach are used to designate 
the estimators utilizing the moment conditions derived in Sections 2.1 and 2.3 respectively. 
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4.1.  Case 1: Without serial correlation 
For Case 1, we set the error structure in the data-generating process to follow Equation (4), 
which does not exhibit serial correlation: 
it i itu a e= + . 
As discussed in Section 2.1, the corresponding initial condition of the data generating process is 
0 1
i
i iy al h-= + , where . . . (0,1)i i di Ua   and . . . (0,1)i i di Nh  . We allow for heteroskedasticity in the 
error term, namely 2(0, )it N ee s , where 2 2, 0 1it itxes q q= + ⋅ . We set 0 0.8q =  and 1 0.2q =  for the 
remainder of the experiment. 
The simulation results appear in Table 1. The upper portion of the table presents mean 
estimates across iterations; the lower portion reports the rejection frequency of the Arellano-Bond 
specification test. As the mean estimates demonstrate, all four methods perform well at recovering 
the model primitives. A slight exception occurs for DGMM estimators, for both traditional and 
SCC methods, as l  approaches 1, where the carryover-rate estimates become slightly downward-
biased. As discussed, this phenomenon embodies the weak-instruments problem, where lagged 
levels lose information as 1l »  and become poor instruments for the first differences. 
As for the test statistics, the null hypotheses for the Arellano-Bond AR(1) and AR(2) tests are 
that there exists no first- and second-order serial correlation, respectively, in the differenced error 
structure. The results show that AR(1) tests are rejected 100% of the time across all models, 
implying that a first-order serial correlation exists among the differences; this is to be expected, as 
ituD  and , 1i tu -D  are correlated through the shared , 1i te -  term by construction. By contrast, the 
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AR(2) tests are not rejected; rejection frequency hovers around 5%, outside of the confidence 
interval. Therefore, the power of the test is shown to be reliable in the absence of serial correlation. 
4.2.  Case 2: With serial correlation 
Next we impose serial correlation on the error structure for data generation. We set the error 
structure according to Equation (8): 
, 1it i it i tu a n ln -= + - . 
The corresponding initial condition for y is replaced by 0 01
i
i i iy al n h-= + + , where . . . (0,1)i i di Ua   
and . . . (0,1)i i di Nh  . As in Case 1, we allow for heteroskedasticity in the serially correlated error 
term, 2(0, )it N nn s , where 2 2, 0 1it itxns q q= + ⋅ . 
The simulation results are reported in Table 2. As the mean estimates show, traditional 
methods’ estimates exhibit a strong bias. Most of the l  estimates in DGMM and SGMM fail to 
recover their true values; as a result, b  estimates also tend to become downward-biased. By 
contrast, the SCC method remains robust. A slight exception appears in the DGMM estimates in 
cases where the true value of l  approaches unity, indicating the weak-instrument problem 
discussed earlier. The SGMM estimates remain robust within the true parameter values across all 
values of l . 
With regard to the power of tests, the AR(1) test precisely detects first-order serial correlation 
in differences across all methods except DGMM when 0.9l = . For AR(2) tests, however, some 
noteworthy patterns are evident. First, regardless of approach (traditional or SCC), the power of 
tests based on DGMM decreases significantly as 1l   due to bias in the estimates arising from 
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the weak-instrument problem. In contrast, the tests based on SGMM remain robust to the weak-
instrument problem, where rejection frequency remains steady over different values of l . Second, 
the tests based on the SCC approach correctly reject the null because the estimates are unbiased; 
by contrast, the power of the test using traditional methods decreases due to bias in the estimates, 
as discussed in Section 3. In the current setting, the SGMM under the traditional approach rejects 
the null on average in only 70% of cases, implying that for the remaining 30% the underlying 
serial correlation could go undetected.4 Third, the low power of the test across both approaches for 
l =0.1 to 0.2 reflects the actual decrease in the degree of serial correlation. 
Overall, the simulation results reveal that, with the existence of serial correlation in the 
idiosyncratic shocks, applying traditional methods can inadvertently yield a severe downward bias 
in the estimates. In practice, this bias may lead to misinterpreting or undermining of the marginal 
effects of the covariates. In contrast, the revised SCC approach is robust in detecting plausible 
serial correlation and recovering the model primitives.  
5.  Empirical Analysis 
This section applies our proposed method to real-world data to properly examine the short- 
and long-term effects of detailing visits in the pharmaceutical industry. Following an institutional 
description of, and data on, the focal firm, we develop our empirical model and discuss our 
findings. Finally, we present a representative case in which traditional methods may fail to detect 
                                                            
4 The power of the test under traditional SGMM decreases monotonically as the variance of serially correlated error 
increases, whereas that of SCC SGMM remain robust. Simulation results for different values of 0q  and 1q  are available 
from the authors on request. 
20 
 
underlying serial correlation and thus falsely justify the use of biased outcomes, leading to 
improper inference. 
5.1.  Data and Institutional Details 
Our focal firm is a highly regarded Fortune 500 company that operates in over 150 countries. 
It offers a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and 
nutritional products. Our empirical analysis utilizes data from the chronic-care sales division of 
the firm’s business operations in India. The data consist of a detailed record of prescriptions 
written by 45,025 physicians over the six-month period from January through June 2016. For each 
physician, we observe the number of prescriptions written, the number of visits by a sales 
representative, and the number of free samples provided to the physician. 
The firm organizes its sales activity by route call sales: each sales representative is assigned a 
series of scheduled visits, within a given time period, to physicians along a set route. Our data are 
unique in that they include the full range of the firm’s brands. Previous studies of detailing 
effectiveness (Parsons and Vanden Abeele, 1981; Manchanda et al., 2004; Mizik and Jacobson, 
2004) have been limited to data on a single brand or a few brands; their results neglect possible 
spillover effects among brands, and are thus apt to underestimate the overall effectiveness of 
detailing. Because firms and managers are likely to be most interested in the impact of sales calls 
(and free samples) on overall performance, we believe that our dataset provides a better measure 
for evaluating the true effect of detailing efforts.5 
                                                            
5 Because the firm does not track the specific brands detailed during each call, we aggregate prescription quantities 
across the firm’s brands to obtain the total number of prescriptions written per month. Though the effectiveness of 
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To fully exploit the nature of a dynamic panel data model, we restrict our attention to 
physicians whose interactions with the sales force are ongoing, and for whom the data include no 
intermissions in prescription history. To explore differences in the effectiveness of sales calls across 
physician specialties, we focus exclusively on the six medical practice areas that account for 
approximately 90% of the active physicians in our data: cardiologists, diabetologists, 
endocrinologists, consulting physicians, general practitioners, and general surgeons. For expository 
purposes, we will refer to the first three groups as specialists and the latter three as generalists. 
These restrictions lead us to focus our attention on N=9,595 physicians over T=6 month horizon.  
Figure 1 depicts the empirical distribution of prescriptions and detailing calls. Figure 1a 
shows the number of prescriptions per month to be highly heterogeneous and right-skewed across 
doctors, implying significant unobserved physician heterogeneity. The number of calls per month, 
illustrated in Figure 1b, shows heterogeneity similar in shape to Figure 1b but also discreteness: 
the majority of observations fall between 1 and 7 visits, in keeping with the firm’s route sales 
procedure (and monthly quotas). 
Tables 3–5 report descriptive statistics by medical practice area for numbers of prescriptions, 
detailing calls, and free samples respectively. Most striking is the magnitude of between-group 
difference: both sales-force efforts and outcomes are, on average, greater for the specialists. 
Heterogeneity in both prescriptions and sales calls within specialists is also noteworthy: although 
the diabetologists write the most prescriptions, sales-force efforts are more intensively targeted at 
the endocrinologists. Among generalists, however, within-group heterogeneity is only modest: 
                                                                                                                                                                                               
detailing may vary from brand to brand, analysis at the aggregate level offers generalizable insights: the firm’s 81 
brands represent a comprehensive cross-section of drugs in the marketplace. 
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consulting physicians generate slightly more attention and sales. The preceding section accounts 
for heterogeneity while addressing the endogeneity issues inherent in using lagged variables to 
represent the dynamics of detailing efforts. 
5.2.  The Empirical Model 
We model doctor i’s prescriptions of the focal firm’s pharmaceutical drugs at time t, Sit, as a 
function of an unobserved doctor-specific effect ia  constant over time, a stock of goodwill Git 
(created by the firm’s sales force), a time-specific effect (reflecting seasonality) td  common to all 
physicians, and an idiosyncratic unobserved component nit such that: 
( )expit i it t itS Ga d n= + + + . 
We use the multiplicative form to prevent overweighting of high-volume prescribers. The stock of 
goodwill Git is assumed to increase with current-period sales efforts xit, but to decay over time, 
taking the geometric decay form of  
2
, 1 , 2 ...it it i t i tG x x xb lb l b- -¢ ¢ ¢= + + +  
where l is the carryover rate (1-l would be the decay rate).6  
Our empirical application uses the total number of detailing calls and free samples provided to 
physician i during month t to create the detailing-effort vector xit. As shown in Section 2.2 and 
typically assumed in the marketing literature as the data-generating process of advertising (Lilien 
et al., 1992: 290), the geometric sum can be replaced by the lagged dependent variable si,t-1. Hence 
our model specification simplifies to  
                                                            
6 Because our model is multiplicative, the parameter l  represents elasticity in the current setting.  
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, 1it i t it t its s x ul b d- ¢= + + +     (12) 
 , 1it i it i tu a n ln -= + -   
where log( )it its S= , (1 )i ia l a= -  , and 1t t td d ld -= -  . 7  Notice that by the geometric sum 
assumption of the stock of goodwill, the error structure, by construction, posits serial correlation. 
For our empirical estimation, we construct moment conditions for Equation (12) by two 
different assumptions with regard to serial correlation, as discussed in Section 2. First, in the 
traditional approach, we utilize levels of time lags t-2 and earlier to instrument for the first 
difference of the lagged dependent variables as in Equation (5)—DGMM, and, in addition, the 
differences of time lags t-1 to instrument for the levels as in Equations (5) and (6)—SGMM. In 
our modified SCC approach, we restrict the use of time lags to t-3 and earlier in DGMM, as in 
Equation (9), and to t-2 in SGMM as in Equations (9) and (10).  
In addition to the endogeneity issue associated with using lagged dependent variables, 
detailing efforts may possess an endogeneity problem because the error component in Equation 
(12) encapsulates any other unobservable factors that affect physicians’ prescriptions. By using an 
extensive set of physician fixed effects, we mitigate this concern. Furthermore, because sales visits 
are scheduled in advance, and as a matter of company policy rarely rescheduled, we believe that 
by treating detailing efforts as predetermined we avoid this endogeneity issue. We limit the total 
number of moment conditions for our predetermined variables, detailing calls and free samples, by 
using only the most recent lag available for the differenced equation to prevent a potential 
                                                            
7 We tested for diminishing returns to detailing efforts by including quadratic terms, as in Manchanda and Chintagunta 
(2004). However, all coefficients for the quadratic terms are found to be insignificant. Thus we exclude them from the 
analysis. 
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overfitting problem.8 Thus, in our SCC approach we utilize 2 , 2E[ ] 0i t itx u- D =  for DGMM, and 
both 2 , 2E[ ] 0i t itx u- D =  and 2 , 2E[ ] 0i t itx u-D =  for SGMM, among the conditions given in Equation 
(11); in the traditional approach, we use lags of t-1 in an analogous manner. 
5.2.1.  Results: A Homogeneous Model 
Table 6 reports parameter estimates of the model given in Equation (12). We first turn our 
attention to the specification test results. The Arellano-Bond test for serial correlation shows that 
both AR(1) and AR(2) are rejected across all specifications. This result implies the existence of 
both first- and second-order serial correlation in the differenced error structure, providing a strong 
rationale for restricted use of the instruments as in our proposed methodology. 
Because serial correlation exists in the unobserved components of the data, the key assumption 
under the traditional methods is not satisfied. Hence the estimates obtained using the improper 
moment conditions of traditional methods, in the first and second columns of Table 6, are biased. 
This is evident in the counterintuitive results, which attribute negative effectiveness to detailing. 
Also, the carryover elasticity estimates become downward-biased, as shown in Section 4.2.  
In the third column of Table 6, the DGMM estimates under the SCC approach, which 
imposes restricted moment conditions, show recovered carryover elasticity measures. However, the 
model suffers from the weak-instruments problem associated with the sole use of levels as 
instruments for differences, and the slope parameters representing the effectiveness of sales efforts 
remain insignificant. Thus, for model inference, we turn our attention to the SGMM estimates 
                                                            
8 We also tested exploiting the full set of moment conditions for the predetermined variables (all available lags of levels, 
given by the second row of Equation (11)); the results were qualitatively similar. 
25 
 
under the SCC approach, which impose proper moment conditions while extracting more 
information from the data to correct for the weak-instrument problem. In the rightmost column of 
Table 6 we find that, on aggregate, the long-term effect—specifically, the carryover effect—is 
0.545, and that in the short term a unit increase in detailing calls elicits a 10.1% increase in 
prescriptions by the physician.9 
5.2.2.  Heterogeneity in Detailing Effectiveness across Specialties 
The preceding section accounts only for permanent heterogeneity via physician fixed effects. In 
reality, firms care about the effectiveness of detailing across different medical specialties. To 
investigate differences in the value of sales efforts across specialties, we allow for different slope 
parameters for each specialty such that 
( ) , 1( )dit i S d i t d it t it
d
s I s x ul b dÎ - ¢= + + +å    (13) 
where ( )di SI Î  is an indicator function that equals one if doctor i is a member of specialty d, Sd. The 
model incorporates heterogeneity by allowing different carryover ( dl ) and detailing effectiveness 
( db ) in different specialties. The estimates for Equation (13) using various moment conditions 
are reported in Table 7. The general observable pattern with regard to different estimation 
methods is analogous to the homogenous model discussed in the previous subsection: presence of 
serial correlation, biased traditional estimators, and inefficiency of DGMM due to weak 
instruments. Thus, for model inference, we again turn our attention to the results from the SGMM 
                                                            
9 We calculated the magnitude of percentage increase using exp(0.096)-1=0.1008 due to the log-transformed dependent 
variable.  
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estimator based on the SCC approach. Three observations are worth noting in Table 7: (1) a 
stronger long-term effect (greater inertia) for specialist physicians, (2) a greater short-term 
marginal effect of detailing for generalist physicians, and (3) a limited effect of free samples. 
The parameter estimates of the lagged dependent variable (carryover effect) are larger for 
specialists, whose elasticity measures range from 0.591 to 0.706. In contrast, those of generalists 
range from 0.388 to 0.566; general surgeons exhibit the lowest inertia. These results imply that the 
long-term effect of sales efforts is more pronounced for specialists: because specialists tend to 
prescribe a narrower range of products, focused on specific symptoms and likely to have few if any 
substitutes, specialists commonly exhibit greater stickiness to a particular product (from a specific 
firm). In contrast, the short-term marginal effect of detailing is larger for generalists, indicating 
willingness to try and then to prescribe new drugs. Generalists typically prescribe a wide range of 
generic drugs, many of which have substitutes from competing firms.   
Thus we observe a general trend: specialists exhibit high inertia and low sensitivity to 
detailing; generalist are less persistent in their prescribing behavior and more responsive to short-
term detailing efforts. We also find that free samples dispensed during detailing calls have trivial 
effects on physicians’ prescribing behavior.   
5.2.3.  Empirical Evidence: Failure of Tests for Serial Correlation  
The analyses reported in the preceding subsections were conducted conditional on the 
Arellano-Bond AR(2) tests being rejected, i.e., on second-order serial correlation sufficiently strong 
to be detected across all methods. Hence, the researcher in those cases would have been cautious 
about applying the traditional dynamic panel data methods, and would have utilized restricted 
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moment conditions (lags t-3 and below) as in our proposed method. This subsection presents a 
case in which the traditional methods fail to reject the model despite the presence of serial 
correlation, leading to biased estimates and incorrect inference. 
For this analysis, we run the model in Equation (12) separately for each physician specialty. 
The results for diabetologists appear in Table 8. We find that the AR(2) test is rejected only 
when the SGMM estimator under the SCC approach is used. As is evident in Table 2, the AR(2) 
test statistic using moment conditions of the traditional approach exhibits weak power and fails to 
reject the null hypothesis of no second-order serial correlation. Also, the AR(2) test statistic for 
DGMM under the SCC approach suffers from both the weak-instruments problem and from the 
moderate effectiveness of explanatory variables, similar to the conditions reported in the rightmost 
columns of the table. 
In this case, the AR(2) test statistic may falsely justifies the misspecified model using the 
unrestricted moment conditions provided by the traditional methods. Thus, by using estimates 
derived from the traditional methods, researchers can mistakenly infer that sales efforts have no 
significant effect (SGMM) or could even yield a negative outcome (DGMM).  
6.  Conclusion 
Personal selling in the form of detailing to physicians is the prevailing go-to-market practice in 
the pharmaceutical industry. Nevertheless, findings on the impact of sales calls have varied widely, 
and controversially, from study to study. Inappropriate methods and imprecise data are the main 
causes of this variation. This paper develops and estimates a generalized model to accurately 
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derive the short- and long-term effects of detailing on physicians’ prescribing behavior. To 
encompass the intertemporal nature of detailing and to control for physician heterogeneity, we 
utilize a dynamic panel data method as the basis of our empirical analysis. 
We introduce a key methodological innovation to the marketing and economics literatures. We 
challenge the widely used serial correlation assumption (or the lack of such an assumption) about 
the error structure in traditional dynamic-panel-data settings and derive a more appropriate set of 
moment conditions that can properly address serial correlation. Such correlation is apt to be 
present in the empirical context of sum of marketing efforts characterized by geometric decay—for 
example, in the advertisement-as-investment model of Nerlove and Arrow (1962), which has been 
extensively utilized in the literature. Using the general structure of a dynamic panel data model, 
we review the validity of instruments with respect to assumptions about serial correlation and 
discuss corresponding plausible moment conditions for estimation.  
We also review the Arellano-Bond specification test for serial correlation, routinely used in 
traditional dynamic panel data settings. We provide proof that, in the presence of serial 
correlation, the test statistic becomes weak and imprecise at detecting it. This shortcoming leads 
to a misuse of moment conditions that results in biased parameter estimates and incorrect 
inference. To validate our claim, we run simulation studies and verify the failure of test statistics 
under traditional methods. We provide a revised set of moment conditions appropriate for 
unbiased identification of model primitives in a dynamic panel data setting. 
For our empirical analyses, we apply our proposed method to comprehensive data on detailing. 
We first show the existence of serial correlation in the data, and the corresponding failure of 
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traditional methods. Inadequate assumptions on serial correlation result in downward bias of 
parameter estimates. By analyzing differences in the effectiveness of detailing across medical 
practice areas, we find a substantial amount of heterogeneity in both persistence and short-term 
responsiveness to detailing efforts. Our results reveal that specialist physicians exhibit a greater 
long-term effect but only modest short-term responsiveness to detailing. In contrast, generalist 
physicians tend to be more responsive to sales calls in the short term, although the effect may not 
be long-lasting. Across all specialties, free samples are minimally effective at generating additional 
prescriptions.  
In summary, this paper provides a simple and practical but rigorous framework to precisely 
analyze the effectiveness of personal selling efforts. We believe that our method and empirical 
insights can help firms allocate sales-force resources more efficiently and devise optimal routes and 
call-pattern designs. Although our empirical application is in the personal-selling domain, our 
model can be extended to other contexts, such as advertising. We believe that doing so will help 
both academics and practitioners to better understand economic phenomena of a dynamic nature. 
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Table 1: Simulation Results without Serial Correlation (Case 1) 
Mean Estimates 
True Value 
l   0.1000 0.2000 0.3000 0.4000 0.5000 0.6000 0.7000 0.8000 0.9000
b   0.9000 0.8000 0.7000 0.6000 0.5000 0.4000 0.3000 0.2000 0.1000
Traditional 
DGMM 
l   0.0989 0.1977 0.2968 0.3981 0.4940 0.5919 0.6883 0.7794 0.8402
b   0.8982 0.7997 0.6989 0.5987 0.4984 0.3998 0.2975 0.1973 0.0944
SGMM 
l   0.1007 0.2008 0.3012 0.4017 0.5019 0.6026 0.7032 0.8053 0.9078
b   0.8989 0.8005 0.7003 0.5995 0.5006 0.4020 0.3001 0.2007 0.0999
SCC 
DGMM 
l   0.0978 0.1959 0.2938 0.3966 0.4878 0.5844 0.6766 0.7635 0.8113
b   0.9021 0.7910 0.6932 0.6013 0.5105 0.4032 0.2959 0.1908 0.0927
SGMM 
l   0.1013 0.2002 0.3013 0.4044 0.5030 0.6031 0.7051 0.8055 0.9087
b   0.9007 0.7878 0.7034 0.6027 0.5099 0.4001 0.2908 0.1954 0.1007
Testing for Serial Correlation (Rejection Frequency in %) 
Traditional 
DGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 7.5 6.0 4.0 6.0 5.0 7.0 2.0 4.5 5.5
SGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 7.0 5.5 4.0 5.0 5.0 6.0 2.5 4.5 3.5
SCC 
DGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 5.0 5.0 5.5 5.5 6.0 6.5 3.5 4.0 5.5
SGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 5.0 6.0 5.0 5.5 4.5 5.0 2.5 4.0 3.0
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Table 2: Simulation Results with Serial Correlation (Case 2) 
Mean Estimates 
True Value 
l   0.1000 0.2000 0.3000 0.4000 0.5000 0.6000 0.7000 0.8000 0.9000
b   0.9000 0.8000 0.7000 0.6000 0.5000 0.4000 0.3000 0.2000 0.1000
Traditional 
DGMM 
l   0.0481 0.0847 0.1092 0.1177 0.1094 0.0861 0.0440 0.0063 -0.0158
b   0.8876 0.7792 0.6652 0.5487 0.4253 0.3030 0.1825 0.0877 0.0224
SGMM 
l   0.0442 0.0749 0.0959 0.1047 0.1034 0.0938 0.0793 0.0743 0.1349
b   0.8898 0.7828 0.6711 0.5567 0.4360 0.3165 0.2000 0.1080 0.0403
SCC 
DGMM 
l   0.0960 0.1955 0.2926 0.3855 0.4816 0.5612 0.6294 0.5778 0.0301
b   0.9003 0.7998 0.6962 0.6143 0.5058 0.4132 0.2988 0.1813 0.0636
SGMM 
l   0.0994 0.2001 0.2988 0.3952 0.4977 0.5915 0.7075 0.8503 0.9637
b   0.9040 0.8045 0.7008 0.6161 0.5019 0.4175 0.2943 0.1978 0.1067
Testing for Serial Correlation (Rejection Frequency in %) 
Traditional 
DGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 32.5 67.0 85.5 87.5 76.5 58.0 25.5 6.5 8.0
SGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 28.5 58.0 70.0 80.5 71.0 66.0 61.0 58.0 72.0
SCC 
DGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 82.5
AR(2) 68.0 99.5 100.0 100.0 100.0 100.0 100.0 99.0 7.5
SGMM 
AR(1) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
AR(2) 71.5 99.5 100.0 100.0 100.0 100.0 100.0 100.0 100.0
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Table 3: Descriptive Statistics: Physician Prescriptions 
 Overall 
Cardio-
logist 
Diabeto-
logist 
Endocrino-
logist 
Consulting
Physician 
General 
Practitioner 
General
Surgeon
Mean 19.96 17.64 40.42 32.63 19.87 17.10 17.77
Standard 
Deviation 
32.53 15.08 106.97 40.61 26.80 17.71 14.74
Maximum 1590.00 220.00 1590.00 377.00 1300.00 760.00 108.00
Minimum 1.00 1.00 1.00 1.00 1.00 1.00 1.00
N 9595 628 422 206 4988 3069 282
 
 
Table 4: Descriptive Statistics: Detailing Calls 
 Overall 
Cardio-
logist 
Diabeto-
logist 
Endocrino-
logist 
Consulting
Physician 
General 
Practitioner 
General
Surgeon
Mean 2.55 2.70 3.23 4.69 2.68 2.10 2.18
Standard 
Deviation 
1.56 1.67 2.05 2.94 1.55 1.14 1.02
Maximum 24.00 16.00 23.00 24.00 23.00 17.00 7.00
Minimum 1.00 1.00 1.00 1.00 1.00 1.00 1.00
 
 
Table 5: Descriptive Statistics: Free Samples 
 Overall 
Cardio-
logist 
Diabeto-
logist 
Endocrino-
logist 
Consulting
Physician 
General 
Practitioner 
General
Surgeon
Mean 3.39 2.50 3.90 4.28 3.69 2.97 3.17
Standard 
Deviation 
17.99 10.48 14.07 32.62 18.27 18.04 15.46
Maximum 1100.00 225.00 340.00 1100.00 1100.00 1050.00 540.00
Minimum 0.00 0.00 0.00 0.00 0.00 0.00 0.00
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Table 6: Estimation Results: Homogenous Model 
 
Traditional  SCC 
DGMM SGMM  DGMM SGMM 
Lagged log(prescription) 0.215 (0.019) 0.254 (0.014) 0.492 (0.038) 0.545 (0.035) 
Detailing Calls -0.016 (0.004) -0.003 (0.004) 0.084 (0.047) 0.096 (0.015) 
Free Samples (×10) 0.005 (0.001) 0.005 (0.001) 0.020 (0.027) -0.001 (0.014) 
Specification Tests  
   Arellano-Bond AR(1) Reject Reject Reject Reject
   Arellano-Bond AR(2) Reject Reject Reject Reject
Number of Instruments 22 35 18 28
Number of Observations 38380 47975 38380 47975
Dependent variable: logarithm of prescriptions per month. Standard errors are reported in 
parentheses. Significance (at the 0.05 level) appears in boldface.  
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Table 7: Estimation Results: Heterogeneous Model 
 
Traditional  SCC 
DGMM SGMM  DGMM SGMM 
Lagged log(prescription)       
 
Cardiologist 0.115 (0.078) 0.238 (0.031)  0.109 (0.213) 0.699 (0.061) 
Diabetologist 0.069 (0.075) 0.394 (0.031)  0.079 (0.399) 0.591 (0.059) 
Endocrinologist 0.018 (0.143) 0.328 (0.030)  0.207 (0.299) 0.706 (0.079) 
Consulting Physician 0.202 (0.029) 0.265 (0.016)  1.176 (0.173) 0.566 (0.040) 
General Practitioner 0.251 (0.041) 0.215 (0.018)  -0.286 (0.132) 0.530 (0.042) 
General Surgeon 0.208 (0.125) 0.232 (0.037)  -0.119 (0.276) 0.388 (0.109) 
Detailing Calls       
 
Cardiologist 0.002 (0.015) 0.015 (0.013)  -0.011 (0.018) -0.015 (0.042) 
Diabetologist -0.036 (0.015) 0.006 (0.013)  -0.029 (0.023) 0.100 (0.036) 
Endocrinologist 0.006 (0.013) 0.032 (0.011)  0.013 (0.017) -0.002 (0.047) 
Consulting Physician -0.022 (0.005) -0.009 (0.005)  0.028 (0.012) 0.092 (0.022) 
General Practitioner -0.005 (0.008) 0.000 (0.007)  -0.040 (0.012) 0.109 (0.034) 
General Surgeon 0.013 (0.031) -0.004 (0.025)  -0.028 (0.042) 0.251 (0.092) 
Free Samples (×10)       
 
Cardiologist 0.002 (0.011) 0.010 (0.010)  0.002 (0.012) 0.057 (0.038) 
Diabetologist 0.012 (0.007) 0.007 (0.005)  0.011 (0.007) 0.023 (0.048) 
Endocrinologist 0.000 (0.002) 0.004 (0.003)  0.001 (0.002) 0.004 (0.012) 
Consulting Physician 0.005 (0.001) 0.005 (0.001)  0.009 (0.002) -0.016 (0.013) 
General Practitioner 0.004 (0.002) 0.004 (0.002)  0.002 (0.001) 0.032 (0.022) 
General Surgeon 0.015 (0.003) 0.010 (0.006)  0.009 (0.005) 0.171 (0.099) 
Specification Tests  
   Arellano-Bond AR(1) Reject Reject Reject Reject
   Arellano-Bond AR(2) Reject Reject Reject Reject
Number of Instruments 112 185 88 143
Number of Observations 38380 47975 38380 47975
Dependent variable: logarithm of prescriptions per month. Standard errors are reported in 
parentheses. Significance (at the 0.05 level) appears in boldface. 
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Table 8: Estimation Results: Diabetologists 
 
Traditional  SCC 
DGMM SGMM  DGMM SGMM 
Lagged log(prescription) 0.118 (0.075) 0.459 (0.063) 0.471 (0.263) 0.639 (0.113) 
Detailing Calls -0.034 (0.016) 0.027 (0.015) 0.105 (0.057) 0.097 (0.037) 
Free Sample (×10) 0.014 (0.006) 0.009 (0.008) 0.098 (0.053) 0.080 (0.054) 
Specification Tests  
   Arellano-Bond AR(1) Reject Reject Reject Reject
   Arellano-Bond AR(2) Not Reject Not Reject Not Reject Reject
Number of Instruments 22 35 18 28
Number of Observations 1688 2110 1688 2110
Dependent variable: logarithm of prescriptions per month. Standard errors are reported in 
parentheses. Significance (at the 0.05 level) appears in boldfce. 
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Figure 1: Distribution of Prescriptions / Calls 
a)  Number of Prescriptions b)  Number of Calls 
 
 
